McLoughlin G A, Wu A V, Saporoschetz I, Nimberg R, Mannick J A
Ann Surg. 1979 Sep;190(3):297-304. doi: 10.1097/00000658-197909000-00004.
In order to clarify the relationship between anergy and immunosuppressive activity in the serum, we studied 46 previously well patients before and at three, five, seven and 28 days after surgery. Delayed hypersensitivity was measured by skin testing with four common recall antigens, and serum immunosuppressive activity was determined by the ability of the patient's serum in 10% concentration to suppress by 50% or more the phytohemagglutinin (PHA) stimulation of normal human lymphocytes as compared to pooled normal serum. Prior to surgery, all patients manifested delayed hypersensitivity to one or more antigens, and no patient had immunosuppressive serum. Fifteen patients underwent minor surgery under general anesthesia and did not develop anergy or immunosuppressive serum. Thirty-one patients underwent major cardiovascular surgery. Thirteen of these patients became anergic by day 3 after operation, and 11 of the 13 developed immunosuppressive serum. Eighteen patients maintained delayed hypersensitivity after major surgery, and only three developed immunosuppressive serum. The correlation between anergy and immunosuppressive serum was highly significant (p < 0.001). There was a significant difference in the degree of suppressive activity in the serum of the anergic and reactive patient groups for each postoperative day studied until day 28, when there was recovery of delayed hypersensitivity and lack of immunosuppressive serum. The occurrence of postoperative anergy and immunosuppressive serum was not related to the patient's age, sex, number of perioperative blood transfusions or duration of anesthesia but was associated with an increase in postoperative infectious complications (p < 0.05) and in postoperative days in the hospital (p < 0.01). Pooled immunosuppressive serum from anergic patients was fractionated by ion exchange chromatography, gel filtration and preparative high voltage electrophoresis. The majority of the immunosuppressive activity could be accounted for by an electrophoretically homogenous polypeptide-containing fraction not identified in the serum of patients undergoing minor surgery or in normal individuals. We conclude that anergy occurring after major operative trauma is associated with the appearance of a circulating immunosuppressive molecular species and that these events are in turn associated with increased patient morbidity and increased length of hospitalization.
为了阐明血清中无反应性与免疫抑制活性之间的关系,我们对46例术前情况良好的患者在手术前以及术后3天、5天、7天和28天进行了研究。通过用四种常见的回忆抗原进行皮肤试验来测定迟发型超敏反应,通过患者10%浓度的血清抑制正常人淋巴细胞对植物血凝素(PHA)刺激的能力达到50%或更高的程度(与混合正常血清相比)来确定血清免疫抑制活性。手术前,所有患者对一种或多种抗原表现出迟发型超敏反应,且无患者有免疫抑制性血清。15例患者在全身麻醉下接受小手术,未出现无反应性或免疫抑制性血清。31例患者接受了大的心血管手术。其中13例患者在术后第3天变得无反应,这13例中的11例出现了免疫抑制性血清。18例患者在大手术后维持迟发型超敏反应,只有3例出现免疫抑制性血清。无反应性与免疫抑制性血清之间的相关性非常显著(p<0.001)。在研究的每个术后日,无反应性患者组和有反应性患者组血清中的抑制活性程度存在显著差异,直到术后28天,迟发型超敏反应恢复且无免疫抑制性血清。术后无反应性和免疫抑制性血清的出现与患者的年龄、性别、围手术期输血次数或麻醉持续时间无关,但与术后感染并发症的增加(p<0.05)以及住院天数的增加(p<0.01)有关。对来自无反应性患者的混合免疫抑制性血清进行离子交换色谱、凝胶过滤和制备性高压电泳分离。大部分免疫抑制活性可由一个电泳均一的含多肽部分来解释,该部分在接受小手术的患者血清或正常个体血清中未发现。我们得出结论,重大手术创伤后出现的无反应性与一种循环免疫抑制分子物质的出现有关,而这些事件反过来又与患者发病率增加和住院时间延长有关。